FDA Inspection
Dana E. Rathkopf , M.D.Dana E. Rathkopf , M.D. – FDA Inspection, May 30, 2014
Record Details
This FDA Inspection record concerns Dana E. Rathkopf , M.D., with an inspection on May 30, 2014, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Dana E. Rathkopf , M.D.
- Inspection Date
- May 30, 2014
- Product Type
- Drugs
View Company Profile
ID · 33590030-e347-4f66-9e54-b2d1c82747cd
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 881278
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
3- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.60Informed consent
- 21 CFR 312.64(b)Safety reports
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Dana E. Rathkopf , M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 24, 2012 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Dana E. Rathkopf , M.D.
- FDA Inspection 792649 - 2012-08-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.